{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Calidi Biotherapeutics, Inc. Common Stock"},"Symbol":{"label":"Symbol","value":"CLDI"},"Address":{"label":"Address","value":"4475 EXECUTIVE DRIVE,SUITE 200, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":null},"Sector":{"label":"Sector","value":null},"Region":{"label":"Region","value":null},"CompanyDescription":{"label":"Company Description","value":"The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index."},"CompanyUrl":{"label":"Company Url","value":null},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Allan J. Camaisa","title":"Chairman & Chief Executive Officer"},{"name":"Amish A. Patel","title":"Senior Vice President-Technical Operations"},{"name":"Antonio F. Santidrian","title":"Chief Scientific Officer"},{"name":"Boris Minev","title":"Chief Medical Officer & President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}